EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA. Materials and Methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to pr...

Full description

Bibliographic Details
Main Authors: Junpeng Liu, Zewen Zhou, Yifan Jiang, Yuzhao Lin, Yunzhi Yang, Chongjiang Tian, Jinwen Liu, Hao Lin, Bin Huang
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
EPH receptor A3
bladder cancer
TCGA
ROC
GEO
overall survival
Online Access:https://www.mdpi.com/2072-6694/15/3/621

Internet

https://www.mdpi.com/2072-6694/15/3/621

Similar Items